Frequently Asked Questions
The market is segmented based on , By Diseases (Cancer and Eye Disorder), Brand Name (Avastin, Mvasi, Zirabev, and Versavo), Dosage (100mg and 400mg), Application (Non Squamous Non-Small Cell Lung Cancer, Recurrent Glioblastoma, Cervical Cancer, Colorectal Cell Cancer, Ovarian Cancer, Proliferative Diabetic Retinopathy, Malignant Glioma, Neurofibromatosis, Pancreatic Cancer, and Others), End-Users (Hospitals, Cancer Supportive Centres, Home Healthcare, Academic and Research Institutes, and Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others) – Industry Trends and Forecast to 2030.
.
The Global Bevacizumab Market size was valued at USD 6679.14 USD million in 2022.
The market report covers data from the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina and rest of South America.
